Movement Alert|Weigao Group Medical Polymer Rises 5.06% in Regular Trading, Sustained Buybacks Combined with Ex-Dividend Date Approaching

Market Focus06-01

On June 1, Weigao Group Medical Polymer rose 5.06% in regular trading, trading at HK$3.45/share, with trading volume of HK$144 million.

On the news front, the company has been actively repurchasing shares on the Hong Kong Stock Exchange, buying back a cumulative 1.29 million shares over four consecutive trading days from May 26 to May 29, spending approximately HK$4.3115 million. As of the latest disclosure, the company has repurchased approximately 50.68 million shares in total, representing 11.22% of the authorized buyback limit of 451.56 million shares. Buyback prices ranged from HK$3.27 to HK$3.44 per share during this period.

Additionally, the company confirmed at its annual general meeting on May 29 a final dividend of RMB 0.06 per share, equivalent to HK$0.0688 per share based on an exchange rate of 1 RMB to 1.147 HKD. The ex-dividend date is set for June 2, making June 1 the last trading day to purchase shares and qualify for the dividend. The record date is June 9, with payment expected on July 10. The combination of sustained buyback activity signaling management confidence and the final window before the ex-dividend date likely contributed to the upward price movement.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment